Análise de dados epidemiológicos de pacientes acompanhadas por neoplasia mamária em um hospital de Fortaleza (CE)

Torres, Danielle; Valente, Paulla Vasconcelos; Feitosa, Gisele Pinto; Matos, Cinara de Fátima Pires de; Mota, Francisca Sheila Xavier; Machado, July Rebeca

doi:10.5327/z201600020002rbm

Cited by 3 publications

(3 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…According to our results, there was predominance of surgery associated with radiotherapy, chemotherapy and hormone therapy, followed by combination of surgery, radiotherapy and chemotherapy, with no evidence of disease after treatment. Results of combination therapy differ from data described in the literature, according to which the most common treatment is surgery plus chemotherapy, as mentioned by Pinheiro et al 16 and Torres et al 28 . Such findings corroborate the results obtained by Barros et al 14 .…”

Section: Discussioncontrasting

confidence: 49%

Breast cancer in Rio Grande do Norte, a retrospective study: epidemiological, clinical and therapeutic profile

Barboza¹,

Ferreira²,

Faustino³

et al. 2017

Rev. Bras. Mastol. (Impr.)

View full text Add to dashboard Cite

Section: Discussioncontrasting

confidence: 49%

Breast cancer in Rio Grande do Norte, a retrospective study: epidemiological, clinical and therapeutic profile

Barboza¹,

Ferreira²,

Faustino³

et al. 2017

Rev. Bras. Mastol. (Impr.)

View full text Add to dashboard Cite

“…In the BIRADS classification of patients, there was a prevalence of classification IV in both periods, data that agree with what was described in a study in which 34.7% of patients were classified as having BIRADS IV 12 .…”

Section: Discussionsupporting

confidence: 89%

Impact of the immunohistochemical panel onpatients with breast cancer diagnosis cared for ina referral hospital in the state of Amazonas

Pereira

Silva

et al. 2020

Mastology

View full text Add to dashboard Cite

Objective: To demonstrate the time between the diagnosis of the disease, the result of the immunohistochemical panel and the beginning of specialized treatment in patients diagnosed with breast cancer seen at the Foundation Center of Oncology of the State of Amazonas, from June to November 2018 and in the same period of 2019. Methods: The study was part retrospective, based on data from medical records, and part prospective, based on data from patients, and we evaluated the time between diagnosis from the immunohistochemical panel and the beginning of specialized treatment in breast cancer patients. Results: 170 patients diagnosed with breast cancer were included, 71 from June to November 2018 and 99 breast cancer patients seen from June to November 2019. The median time between diagnosis and immunohistochemistry results of all patients was 36 days, and comparing the two groups of patients, it was observed that for half of the 2018 patients, the time was less than 105 days, while for half of the 2019 patients, it was less than 27 days. If the times between the result of the immunohistochemical panel and the start of personalized treatment in both groups were compared, it was seen that the median time until the start of treatment was longer for patients in 2018, 94.5 days versus 79 days for patients in 2019. Conclusion: There was a decrease in the time between the diagnosis and the result of the molecular panel in 2019 compared to 2018. Achieving this result more quickly provided the choice of personalized treatment for each patient, having an important impact on survival in that population.

show abstract

“…A neoplasia mamária é o segundo tipo mais comum de câncer, e o mais prevalente entre as mulheres (ANDRADE; PANZA; VARGENS, 2011). No que concerne à faixa etária, é notável nos dados obtidos uma presença significativa de mulheres jovens com esse diagnóstico, sendo este dado contrário às estimativas do INCA, em quea incidência é rara antes dos 35 anos e cresce relativamente com o aumento da idade, com um enfoque especial para mulheres acima dos 50 anos e que se encontram na perimenopausa (INCA, 2018;TORRES et al, 2016).…”

Section: Perfis Dos Participantes Da Pesquisaunclassified

Impacto do Diagnóstico e do Tratamento do Câncer de Mama em Mulheres Mastectomizadas

et al. 2020

View full text Add to dashboard Cite

O câncer de mama (CM) é uma neoplasia que acomete principalmente pessoas do sexo feminino. O tratamento para o CM engloba intervenções locais, tais como: as cirurgias conservadoras e a mastectomia e/ou intervenções sistêmicas. Desse modo, o objetivo do presente estudo foi compreender o impacto do diagnóstico e do tratamento do CM para mulheres que foram submetidas à mastectomia. O estudo é descritivo-exploratório com abordagem qualitativa, realizado na cidade de Barbalha, Ceará. Para organização, análise e interpretação dos dados foi utilizada a categorização temática de Minayo. Participaram da pesquisa 11 mulheres na faixa etária de 25 a 55 anos. Utilizando a análise proposta, foram elencadas três categorias: “câncer de mama e seu significado”; “diagnóstico do câncer: mudanças e tratamento” e “mastectomia e feminilidade”. Observou-se que as mulheres submetidas à mastectomia precisam expressar resiliência para prosseguir com o tratamento e para lidar, de forma positiva, com as alterações percebidas na imagem corporal. Assim, a análise dos dados permitiu concluir que o diagnóstico e os impactos com o tratamento contemplam aspectos biológico, psíquico e social. Portanto, pelo fato dessas mulheres sofrerem diversas alterações em suas rotinas diárias, elas necessitam de sistemas de apoio congruentes e alicerçados no âmbito assistencial, familiar e comunitário. Palavras-chave: Neoplasia. Mastectomia. Saúde da Mulher. Abstract Breast cancer (BC) affects especially women. Treatment for BC involves local interventions - such as conservative surgery and mastectomy - and/or systemic therapy. Thus, the aim of the present study was to understand the impact of BC diagnosis and treatment for women undergoing mastectomy. The study is descriptive and exploratory with qualitative approach, conducted in the city of Barbalha, Ceará. For data organization, analysis and interpretation, Minayo's thematic categorization was used. Eleven women aged 25 to 55 years participated in the research. Using the proposed analysis, three categories were listed: “breast cancer and its meaning”; “Cancer diagnosis: changes and treatment” and “mastectomy and femininity”. It has been observed that women undergoing mastectomy need to express resilience to proceed with treatment and to deal positively with perceived changes in body image. Thus, the data analysis allowed to conclude that the diagnosis and the impacts with the treatment include biological, psychic and social aspects. Therefore, because these women suffer several changes in their daily routines, they need congruent support systems based on care, family and community. Keywords: Neoplasia. Mastectomy. Women's Health.

show abstract

Análise de dados epidemiológicos de pacientes acompanhadas por neoplasia mamária em um hospital de Fortaleza (CE)

Cited by 3 publications

References 4 publications

Breast cancer in Rio Grande do Norte, a retrospective study: epidemiological, clinical and therapeutic profile

Breast cancer in Rio Grande do Norte, a retrospective study: epidemiological, clinical and therapeutic profile

Impact of the immunohistochemical panel onpatients with breast cancer diagnosis cared for ina referral hospital in the state of Amazonas

Impacto do Diagnóstico e do Tratamento do Câncer de Mama em Mulheres Mastectomizadas

Contact Info

Product

Resources

About